CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline AEMD Q1 2026 Earnings Narrower Slight Loss Surprise Supports Share Recovery HLT Q1 2026 Earnings EPS Beats Estimates by 117 Amid Modest Stock Decline CNO Q1 2026 Earnings EPS Beats Estimates by Nearly 11 Despite Modest Stock Decline SDST Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Phase PANW Q1 2026 Earnings Strong EPS Beat Amid Robust Cybersecurity Demand